Results 151 to 160 of about 31,699 (207)

Case Commentary: When susceptibility is not enough in recurrent <i>Burkholderia cenocepacia</i> infection. [PDF]

Antimicrob Agents Chemother
Giuliano S, Gaibani P, Tascini C.
europepmc   +1 more source

Transcriptome-constrained genome-scale metabolic modeling reveals central carbon and amino acid metabolic reprogramming underlying colistin-sulbactam synergy in <i>Acinetobacter baumannii</i>. [PDF]

Antimicrob Agents Chemother
Bian X, Zhu Y, Liu X, Li X, Li W, Zhao J, Li J, Zhang J.   +7 more
europepmc   +1 more source

Decoding resistance: a comprehensive study on pathogens and antibiotic efficacy in periprosthetic joint infections. [PDF]

J Orthop Surg Res
Hahn N, Jäger M, Wegner A, Schulte TL, Busch A.   +4 more
europepmc   +1 more source

Performance of the Qvella FAST system with downstream application of MALDI-TOF-MS, VITEK 2, and β-LACTA test for same-day identification and antimicrobial susceptibility testing of Gram-negative rods directly from positive blood cultures. [PDF]

Microbiol Spectr
Esse J, Krappmann A-B, Honold K, Träger J, Valenza G, Bogdan C, Held J.   +6 more
europepmc   +1 more source

Real-World Clinical Outcomes of Sulbactam-Durlobactam Against Carbapenem-Resistant <i>Acinetobacter baumannii</i> with Diverse <i>β</i>-Lactamase Profiles: A Multicenter Study in China. [PDF]

Infect Drug Resist
Liu C, Chen Y, Wang L, Wang J, Xu D, Chen Z, Shu C, He Y.   +7 more
europepmc   +1 more source

Cerebrospinal Pharmacokinetic and Pharmacodynamic Evaluation of Sulbactam: Dosing Considerations for Acinetobacter baumannii Meningitis in Pediatric Patients. [PDF]

J Pediatric Infect Dis Soc
Onita T, Ikawa K.
europepmc   +1 more source

Case Report: Catheter-associated multidrug-resistant <i>Leclercia adecarboxylata</i> bloodstream infection in a colon tumor patient. [PDF]

Front Med (Lausanne)
Du N, You D, Chen Z.
europepmc   +1 more source

Microbiological eradication of XDR <i>Acinetobacter baumannii</i> intra-abdominal infection using sulbactam-durobactam: clinical and microbiological outcomes amidst irreversible host comorbidities. [PDF]

Front Med (Lausanne)
Yu L, He J, Chan W, Zou S, Zhou Q, Jin J.   +5 more
europepmc   +1 more source

Genomic epidemiology of carbapenem resistance in <i>Acinetobacter baumannii</i> in Chile. [PDF]

JAC Antimicrob Resist
Araya-Vega P, Matus-Köhler M, Mardones-Verdugo V, Gómez-Inostroza S, González-Muñoz P, Paredes-Osses E, Roach-Poblete F, González-Rocha G, Opazo-Capurro A.   +8 more
europepmc   +1 more source